Pricing
Two flexible ways to bring MindMetrix into your workflow
MindMetrix pricing is designed to flex with the realities of modern clinical care. Whether you’re a solo clinician, a growing group practice, or a large enterprise seeking scalable diagnostic support, our payment models are built to meet you where you are.
Subscription
PopularPredictable monthly pricing for practices using MindMetrix regularly
Starting at $199/month (Results review eligible for reimbursement with CPT 96130)
Unlimited testing (after first tier)
Follow-up testing at your desired cadence
Best for clinics wanting predictable, scalable costs
Patient-Pay
Completely free for your practice; patients cover the assessment fee
Starting at $59 per assessment (HSA/FSA eligible)
No cost to your practice: patients pay at the start of the assessment
Ideal for occasional or supplemental testing
Great for trying MindMetrix before committing
CPT code 96130 can often be billed for reviewing testing with a patient
Psychiatrists, psychiatric NPs, primary care physicians, PAs can bill for incorporating data from comprehensive psychological testing into evaluations, often doubling the value of these visits. Reimbursements and coverage will vary depending on your contracts with insurance providers.
Subscription
Give your team the ultimate tool to "get it right," right away.
Interested in a subscription plan?
Patient-Pay
We’re offering this payment option in response to our conversations with many of you about your use of pharmacogenetic testing, and your feedback that patients are increasingly comfortable paying out of pocket for services that personalize and enhance their care.
Completely free for your practice; patients cover the assessment fee
Ideal for occasional or supplemental testing
Starting at $59 per assessment (HSA/FSA eligible)
Great for trying MindMetrix before committing
No cost to your practice: patients pay at the start of the assessment
What Providers Across the U.S. are Saying
Get a sample report
Sign up for our newsletter and receive a sample report. Plus be the first to know about our new releases and insights.